TipRanks
Advertisement
Advertisement
Oxford Biomedica posts H1 revenue growth and reiterates 2026 guidance
PremiumCompany AnnouncementsOxford Biomedica posts H1 revenue growth and reiterates 2026 guidance
12d ago
Oxford Biomedica Confirms Total Voting Rights at 121 Million Shares
Premium
Company Announcements
Oxford Biomedica Confirms Total Voting Rights at 121 Million Shares
1M ago
Oxford Biomedica downgraded to Hold from Buy at Deutsche Bank
Premium
The Fly
Oxford Biomedica downgraded to Hold from Buy at Deutsche Bank
2M ago
Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline
PremiumCompany AnnouncementsOxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline
2M ago
Oxford Biomedica Sets Updated Voting Rights Total at 121 Million Shares
Premium
Company Announcements
Oxford Biomedica Sets Updated Voting Rights Total at 121 Million Shares
2M ago
Oxford Biomedica Confirms 121 Million Voting Rights in Updated Share Capital
Premium
Company Announcements
Oxford Biomedica Confirms 121 Million Voting Rights in Updated Share Capital
3M ago
Oxford Biomedica Sets Total Voting Rights at 121 Million Shares
PremiumCompany AnnouncementsOxford Biomedica Sets Total Voting Rights at 121 Million Shares
4M ago
Oxford Biomedica Director Joins Board of Nasdaq-Listed Stevanato Group
Premium
Company Announcements
Oxford Biomedica Director Joins Board of Nasdaq-Listed Stevanato Group
4M ago
Oxford Biomedica Executives Exercise Deferred Bonus Options and Sell Shares
Premium
Company Announcements
Oxford Biomedica Executives Exercise Deferred Bonus Options and Sell Shares
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―